How to optimize the clinical therapeutic protocol for triple-positive breast cancer.
- Author:
Ning WANG
;
Ya-jie WANG
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal;
therapeutic use;
Antibodies, Monoclonal, Humanized;
Antineoplastic Agents, Hormonal;
therapeutic use;
Breast Neoplasms;
metabolism;
pathology;
therapy;
Female;
Humans;
Lymphatic Metastasis;
Receptor, ErbB-2;
metabolism;
Receptors, Estrogen;
metabolism;
Receptors, Progesterone;
metabolism;
Signal Transduction;
Tamoxifen;
therapeutic use;
Trastuzumab
- From:
Chinese Journal of Oncology
2010;32(4):241-243
- CountryChina
- Language:Chinese
